Clinical Trial Update: S0007 - Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Head and Neck Cancer [Phase 2]

View source ↗

Summary

A completed Phase 2 trial sponsored by SWOG evaluating combination chemotherapy for patients with metastatic or recurrent head and neck cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Head and Neck Cancer | Phase 2 | Status: COMPLETED